Track topics on Twitter Track topics that are important to you
Cellectis is developing a new type of chimeric antigen receptor that could improve the production and safety of CAR-T cell therapies generated from both patient and donor cells. Cellectis, a French biotech focused on developing CAR-T therapies from donor cells, ...
The post French Biotech Develops a New Generation of Safer CAR-T Cells appeared first on Labiotech.eu.
Original Article: French Biotech Develops a New Generation of Safer CAR-T CellsNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...